PMCK poised for growth with IPO plans 


PETALING JAYA: PMCK Bhd, a private healthcare provider enroute to listing on the ACE Market of Bursa Malaysia, intends to pay at least 20% of its net profit as a dividend going forward.

TA Research assumes a dividend payout of 20% to 44% across financial year 2025 (FY25) to FY27 and projects forward yields to be at 1.3% to 2.1%.

TA Research said for its initial public offering (IPO) price of 22 sen a share, PMCK is priced at a trailing price earnings ratio (PE) of 15.9 times based on FY24 earnings per share (EPS).

The research house forecast a target PE of 16 times FY26 EPS for the counter, while deriving a fair value of 23 sen a share.

PMCK is operating the Putra Medical Centre in Alor Setar, Kedah and has been in the business for over 30 years, offering specialist consultant services and clinical support, with 40 consultants across 17 specialisations. PMCK will raise RM60mil through its IPO on Bursa Malaysia.

It wants to strengthen its presence in northern Malaysia to attract patients and drive long-term revenue growth.

Thus far, Kedah has one of the lowest private hospital bed densities in Malaysia, highlighting a significant gap in private healthcare access.

As part of its expansion, PMCK is constructing a new medical centre, PMC Kulim, with operations targeted to start by the first quarter of financial year 2028 (1Q28).

The 12-storey private medical centre comes with a seven-storey mixed development comprising a four-storey hotel with a two-storey food court and carparks.

PMCK will consolidate the RYM DX Laboratory Sdn Bhd (medical lab) into PMC Kulim by 1Q28 to cater to increasing demand for diagnostic services.

It will upgrade the equipment and facilities in PMC Kedah under clinical support services (medical lab) and facilities services (radiology unit).

TA Research projects net profit to contract by 24.8% to RM11.3mil in FY25, as it expects patient numbers to drop by 20% due to the flooding in Alor Setar and surrounding areas, which hindered patient access.

It expects the profit after tax margin to decline to 12.1% (versus 14.4% in FY24) due to softer patient volumes and higher administrative expenses as PMCK’s facilities remained fully operational during the heavy rainfall between September and December 2024.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Trading ideas: AirAsia, EcoWorld, TMK Chemical, Zetrix AI, Jati Tinggi, Vestland, Capital A, TSR Capital, ES Sunlogy
Global rate-hike cycle expected to be muted
GCash owner gets nod for US$1.47bil IPO
CPO strength, iSPOC set to boost Johor Plantations’ FY27 margins
Nvidia-backed DC firm Nscale files for listing
El Nino impact to weigh on corporate earnings
Paramount settlement talks include promise to stay in California
ProEnergy eyes US$50bil IPO valuation
Uneven gains ahead for semiconductors
Blackstone sees India nearing capital tipping point

Others Also Read